{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T09:06:15Z","timestamp":1779527175572,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Shanghai Municipality Science and Technology Commission","doi-asserted-by":"publisher","award":["21Y11913100"],"award-info":[{"award-number":["21Y11913100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bbadis.2025.168095","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:48:25Z","timestamp":1761810505000},"page":"168095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting autophagy to enhance Nectin-4-MMAE efficacy in gastric cancer"],"prefix":"10.1016","volume":"1872","author":[{"given":"Lu","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingpai","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XuSheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.168095_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2025.168095_bb0010","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2025.168095_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11427-023-2423-1","article-title":"Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors","volume":"67","author":"He","year":"2024","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.bbadis.2025.168095_bb0020","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317714626","article-title":"Progress in the treatment of advanced gastric cancer","volume":"39","author":"Song","year":"2017","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168095_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1523-5394.1999.07205.x","article-title":"Perception of chemotherapy side effects cancer versus noncancer patients","volume":"7","author":"Lindley","year":"1999","journal-title":"Cancer Pract."},{"key":"10.1016\/j.bbadis.2025.168095_bb0030","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s12325-017-0519-6","article-title":"Antibody\u2013drug conjugates (ADCs) for personalized treatment of solid tumors: a review","volume":"34","author":"Lambert","year":"2017","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bbadis.2025.168095_bb0035","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1002\/jcp.27419","article-title":"Antibody\u2013drug conjugates (ADCs) for cancer therapy: strategies, challenges, and successes","volume":"234","author":"Abdollahpour-Alitappeh","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2025.168095_bb0040","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/ijc.30276","article-title":"Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T-DM1) vs. treatment of physician\u2019s choice in previously treated HER2-positive advanced breast cancer","volume":"139","author":"Kim","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2025.168095_bb0045","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-021-00584-y","article-title":"Quantitative evaluation of the effect of antigen expression level on antibody\u2013drug conjugate exposure in solid tumor","volume":"23","author":"Bussing","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.bbadis.2025.168095_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020447","article-title":"Antibody-drug conjugates: the dynamic evolution from conventional to next-generation constructs","volume":"16","author":"Metrangolo","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2025.168095_bb0055","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1158\/0008-5472.CAN-22-2324","article-title":"The dawn of the antibody\u2013drug conjugates era: how T-DM1 reinvented the future of chemotherapy for solid tumors","volume":"82","author":"Tarantino","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.168095_bb0060","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s40265-021-01614-x","article-title":"Disitamab vedotin: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.bbadis.2025.168095_bb0065","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/ijc.30870","article-title":"DS-8201a, a new HER2-targeting antibody\u2013drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance","volume":"141","author":"Takegawa","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2025.168095_bb0070","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1158\/1078-0432.CCR-22-0456","article-title":"Phase I trial of a novel anti-HER2 antibody\u2013drug conjugate, ARX788, for the treatment of HER2-positive metastatic breast cancer","volume":"28","author":"Zhang","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2025.168095_bb0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.humpath.2017.10.034","article-title":"Nectin-4 promotes gastric cancer progression via the PI3K\/AKT signaling pathway","volume":"72","author":"Zhang","year":"2018","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbadis.2025.168095_bb0080","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1158\/0008-5472.CAN-15-1313","article-title":"Enfortumab vedotin antibody\u2013drug conjugate targeting Nectin-4 is a highly potent therapeutic agent in multiple preclinical cancer models","volume":"76","author":"Challita-Eid","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.168095_bb0085","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4161\/auto.26927","article-title":"Autophagy-mediated regulation of macrophages and its applications for cancer","volume":"10","author":"Chen","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2025.168095_bb0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/med.21531","article-title":"The multifaceted role of autophagy in cancer and the microenvironment","volume":"39","author":"Folkerts","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbadis.2025.168095_bb0095","article-title":"Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2025.168095_bb0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/2326-6066.CIR-16-0398","article-title":"Targeting CD47 and autophagy elicited enhanced antitumor effects in non\u2013small cell lung cancer","volume":"5","author":"Zhang","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbadis.2025.168095_bb0105","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1007\/s12035-015-9377-x","article-title":"Cocaine-mediated autophagy in astrocytes involves sigma 1 receptor, PI3K, mTOR, Atg5\/7, Beclin-1 and induces type II programed cell death","volume":"53","author":"Cao","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2025.168095_bb0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4161\/15548627.2014.994368","article-title":"Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia","volume":"11","author":"Zeng","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2025.168095_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.137","article-title":"A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor","volume":"8","author":"Shen","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.168095_bb0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12079-016-0352-8","article-title":"VEGF-A\/VEGFR2 signaling network in endothelial cells relevant to angiogenesis","volume":"10","author":"Abhinand","year":"2016","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.bbadis.2025.168095_bb0125","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/s41388-017-0045-7","article-title":"Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies","volume":"37","author":"An","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2025.168095_bb0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.07.013","article-title":"IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer","volume":"118","author":"Greten","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.168095_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007479","article-title":"TP53\/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma","volume":"11","author":"Yu","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbadis.2025.168095_bb0140","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1158\/1535-7163.MCT-11-0727","article-title":"The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics\/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates","volume":"11","author":"Erickson","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.bbadis.2025.168095_bb0145","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2174\/138920012802138598","article-title":"Catabolic fate and pharmacokinetic characterization of trastuzumab emtansine (T-DM1): an emphasis on preclinical and clinical catabolism","volume":"113","author":"Shen","year":"2012","journal-title":"Curr Drug Metab."},{"key":"10.1016\/j.bbadis.2025.168095_bb0150","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1470-2045(17)30111-0","article-title":"Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2\/3 study","volume":"18","author":"Thuss-Patience","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2025.168095_bb0155","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/carcin\/bgz104","article-title":"Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma","volume":"41","author":"Liu","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2025.168095_bb0160","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/s12967-025-06595-z","article-title":"The dual role of autophagy in cancer stem cells: implications for tumor progression and therapy resistance","volume":"23","author":"Jia","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbadis.2025.168095_bb0165","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4161\/auto.6.7.13038","article-title":"Autophagic degradation of active caspase-8","volume":"6","author":"Hou","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2025.168095_bb0170","article-title":"Targeting p53 pathways: mechanisms, structures and advances in therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2025.168095_bb0175","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.biomaterials.2012.10.034","article-title":"Rapamycin encapsulated in dual-responsive micelles for cancer therapy","volume":"34","author":"Chen","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbadis.2025.168095_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/cdd.2012.81","article-title":"The pathways of mitophagy for quality control and clearance of mitochondria","volume":"20","author":"Ashrafi","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2025.168095_bb0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.carbpol.2019.01.064","article-title":"Polysaccharides as potential anticancer agents\u2014a review of their progress","volume":"210","author":"Khan","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bbadis.2025.168095_bb0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13238-016-0323-0","article-title":"Antibody-drug conjugates: recent advances in conjugation and linker chemistries","volume":"9","author":"Tsuchikama","year":"2016","journal-title":"Protein Cell"},{"key":"10.1016\/j.bbadis.2025.168095_bb0195","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2229101","article-title":"Exploration of the antibody\u2013drug conjugate clinical landscape","volume":"15","author":"Maecker","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.bbadis.2025.168095_bb0200","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/cdd.2017.165","article-title":"N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux","volume":"25","author":"Ranieri","year":"2017","journal-title":"Cell Death Differ."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925004454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925004454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:24:03Z","timestamp":1779524643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925004454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0925443925004454"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168095","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting autophagy to enhance Nectin-4-MMAE efficacy in gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168095"}}